Evidence Synthesis
RAAJMEDI experienced a significant shift in its quarterly performance.
The company's gross margin accelerated to , up from 8.31%. This represents a substantial improvement of 27.36 percentage points. RAAJMEDI's marginal operating leverage also accelerated to , up from 2.26%. The company's revenue growth year-over-year increased to . In contrast, the daily volume declined to 100 shares, a decrease of 27.15% from the previous day. The close price remained unchanged at 75.01 INR.